Hearing Loss as a Potentially Modifiable Marker of Dementia Risk: Neurological Evidence, Uncertainty, and Clinical Interpretation Authors: Verónica Fuentes-Santamaría, Carmen María Díaz García, Juan Carlos Alvarado Published: 2026 ABSTRACT AbstractBackgroundHearing impairment has emerged as a consistently associated and potentially modifiable risk factor for cognitive decline and dementia, including Alzheimer’s disease (AD). Epidemiological studies demonstrate an increased dementia risk among individuals with hearing loss, with evidence of dose-response relationships across levels of auditory decline. Despite the robustness of this association, the mechanisms linking auditory dysfunction to cognitive deterioration remain multifactorial and incompletely understood.SummaryBy integrating biological, cognitive, and psychosocial perspectives while explicitly addressing persistent uncertainties, this critical narrative review provides a balanced framework for interpreting the relationship between hearing impairment and AD. Current evidence points to several interacting pathways, including sensory deprivation, cortical reorganization, increased cognitive load, and psychosocial consequences like social isolation. Furthermore, emerging research suggests that central auditory processing deficits may represent early functional markers of cortical vulnerability associated with neurodegeneration. Clinically, these insights emphasize the importance of routine hearing assessment in older adults, while observational evidence indicates that hearing rehabilitation, particularly hearing aid use, may be associated with more favorable cognitive outcomes.Key MessagesAssociation vs. causation: hearing loss should be regarded as a robustly associated and potentially modifiable marker of dementia risk rather than a confirmed causal determinant. Neurological implication: from a neurological standpoint, central auditory dysfunction may reflect underlying brain vulnerability in aging rather than acting as a direct causal driver of AD. Clinical outlook: while causal effects of hearing rehabilitation have yet to be firmly established, prioritizing hearing health offers a promising and practical avenue for dementia prevention and clinical practice. Introduction Hearing loss represents the most widespread neurosensory alteration globally, with age-related hearing loss (ARHL) identified as the single most common sensory disorder worldwide [1–3]. Accordingly, more than 430 million people were living with disabling hypoacusis in 2025, a number expected to rise if effective public-health measures are not implemented [4]. The etiopathogenesis of this sensorineural condition is multifactorial, involving vascular issues, senescence, acoustic trauma, pharmaceutical toxicity, inherited predisposition, and infectious agents (Fig. 1) [5–7]. Together, these factors contribute to the growing global burden of auditory impairment, highlighting its relevance as a significant public-health challenge requiring coordinated preventive and therapeutic strategies. Over the last few years, hearing impairment has become increasingly recognized as one of the most significant sensory contributors to cognitive decline in aging populations, attracting growing attention across neurology, audiology, geriatrics, and public health [5, 8]. Recently, large-scale collaborative reports, such as the Lancet Commission on Dementia Prevention, Intervention and Care, have consistently identified hearing loss as one of the most prominent potentially modifiable risk factors for dementia at the population level, alongside other well-established contributors such as hypertension, depression, and physical inactivity [9, 10]. This perspective is further supported by several independent narrative and mechanistic reviews that have consistently highlighted ARHL as a major contributor to cognitive vulnerability in aging populations, integrating epidemiological findings with biological and functional evidence across peripheral and central auditory pathways [11, 12]. Major risk factors contributing to hearing loss. Schematic overview of the main etiological factors associated with hearing loss. The central diagram represents the auditory system, surrounded by major contributing factors including vascular risk, aging processes, noise exposure, ototoxic agents, genetic predisposition, and infectious causes, highlighting the multifactorial nature of hearing impairment. These observations have been supported by a substantial body of epidemiological evidence, such as large-scale cohort studies and meta-analyses showing that people with hearing impairment face an elevated likelihood of developing cognitive decline and dementia, including Alzheimer’s disease (AD) [13]. Also, a comprehensive review has further supported this link, indicating that hearing impairment is associated with a substantially increased risk of dementia across diverse demographic and geographic populations [14]. Together, these findings highlight a strong and globally consistent association between hearing impairment and cognitive decline and dementia across diverse populations. A key consideration is that many epidemiological studies assess all-cause dementia outcomes, and distinctions between dementia subtypes, particularly AD, are not always consistently addressed, which may contribute to interpretative ambiguity. Importantly, rankings of modifiable risk factors are based on population-attributable fractions and do not necessarily reflect the relative importance of individual-level risk, which may be greater for conditions such as depression, traumatic brain injury, diabetes, or low educational attainment. Accordingly, several authors have emphasized that population-level risk estimates may overstate causal interpretations at the individual level, particularly in the presence of shared age-related determinants, heterogeneous exposure definitions, and differences in healthcare-seeking behavior that are difficult to fully capture in observational models [15, 16]. Despite this mounting evidence, the pathways linking hearing impairment to neurodegenerative processes are not yet fully understood. The relationship appears to be driven by multiple factors, involving an interplay of biological, cognitive, and social mechanisms [5, 6, 8, 17]. The complexity of this association has been highlighted in a new study proposing that hearing loss might “cause, catalyze, or result” from neurodegenerative changes, suggesting bidirectional interactions between auditory dysfunction and Alzheimer’s pathology [8]. At the biological level, converging research indicates that ARHL and AD may share underlying mechanisms, including peripheral and central neuroinflammation, amyloid-beta (Aβ) and tau-related pathology, and structural degradation in auditory and associative cortical regions [5, 6, 8, 17]. Animal and human studies provide additional mechanistic clues, showing that induced or naturally occurring hypoacusis can impair cognitive performance and may be associated with increased levels of phosphorylated tau in cerebrospinal fluid, offering potential early biomarkers of neurodegenerative vulnerability [5, 8]. At the cognitive and social levels, hypotheses such as sensory deprivation, increased cognitive load, and social isolation offer explanatory frameworks that connect peripheral auditory decline with higher-order cognitive deterioration [6, 8, 18–20]. Sensory deprivation may trigger accelerated atrophy in auditory and memory-related cortical structures, whereas chronic listening effort may divert cognitive resources away from memory and executive processing [6, 8, 19, 21–24]. Social withdrawal, frequently observed in individuals with hearing impairment, further compounds these effects by reducing cognitive stimulation and social engagement, factors known to influence dementia risk [19, 20, 25]. Given the convergence of epidemiological evidence, biological plausibility, and mechanistic hypotheses, understanding the pathways from hearing impairment to neurodegeneration has become an essential endeavor. This critical narrative review synthesizes current knowledge on these interconnected pathways, examines emerging evidence linking auditory dysfunction and AD, and highlights the clinical implications of framing hearing loss as a potentially modifiable risk factor for neurodegeneration. A substantial body of previous reviews has systematically characterized both the epidemiological evidence and the proposed mechanistic pathways relating hearing loss to cognitive decline [13, 26]. However, despite the strength and consistency of these associations, important uncertainties persist regarding causality, underlying mechanisms, and clinical interpretation. In particular, it remains unclear to what extent hearing loss represents a modifiable causal factor, a marker of broader age-related vulnerability, or an early manifestation of neurodegenerative processes. While numerous reviews have summarized the epidemiological evidence and proposed mechanisms linking hearing loss and cognitive decline, the field remains characterized by conceptual ambiguity regarding causality and clinical interpretation. Accordingly, the present review does not aim to provide an additional descriptive synthesis but rather to critically reframe the current evidence by explicitly integrating epidemiological, biological, and clinical perspectives within a framework that emphasizes uncertainty, bidirectionality, and the distinction between hearing loss as a risk marker versus a causal determinant of dementia. Epidemiological Evidence Over the past decade, epidemiological evidence has solidified hearing loss as one of the most consistent and robust risk markers at the population level for the development of dementia, including AD, specifically. Recognizing this auditory dysfunction as the most significant modifiable midlife risk factor for dementia, highlighted in successive reports from the Lancet Commission [9, 10], has marked a turning point in cognitive aging research, placing auditory health at the center of global prevention strategies. Large-scale cohort studies have been essential for quantifying the magnitude of this risk [13, 14, 27]. As previously mentioned, a recent systematic review and meta-analysis of 49 studies conducted across North America, Europe, Asia, and Oceania found that hearing loss is associated with an increased risk of dementia, with hazard ratios ranging from 1.28 to 2.39 [14], demonstrating a strong and consistent global relationship. The analysis also emphasizes that risk levels do not vary significantly by region, suggesting that the association between impaired hearing and cognitive decline transcends cultural, healthcare, and sociodemographic differences [14]. The strength of this link has been further reinforced by a meta-analysis involving unprecedented population sizes. One study analyzing data from over 1.5 million adults reported that hearing loss increases the risk of dementia by 35%, the risk of mild cognitive impairment by 29%, and the risk of AD by 56% [13]. It also identified a clear dose-response relationship; every 10 dB deterioration in hearing is associated with a 16% increase in the likelihood of developing dementia [13]. These findings not only enhance the epidemiological plausibility of the connection but also underscore the importance of considering hearing-loss thresholds as graded indicators of cognitive risk. Additional research using large population-based databases has also shown significant associations between hearing impairment and dementia, even after rigorous adjustment for confounding variables [27]. A Danish study involving more than 573,000 adults found that hearing loss was associated with a 7% increase in dementia risk and that severe hypoacusis heightened this risk by up to 20% in the better-hearing ear [27]. These results reinforce the broader trend observed across studies where the severity of auditory impairment is a meaningful predictor of future cognitive decline. Taken together, this body of research provides a clear epidemiological picture in which hypoacusis is not merely an accompaniment to aging but a significant clinical and population level marker with a measurable impact on cognitive trajectories. Notably, a proportion of the epidemiological evidence is derived from partially overlapping large-scale datasets (e.g., UK Biobank), which may limit the independence of some findings across studies, although sensitivity analyses have generally reported consistent associations. Its modifiable nature, unlike other risk factors for AD, positions hearing health as a priority target for preventive strategies, highlighting the need to integrate systematic hearing screenings and promote early interventions within public health programs focused on healthy aging. It is also important to distinguish between potential delay of dementia onset and true prevention as these concepts carry different implications for clinical practice and public health messaging. Mechanisms Linking Hearing Loss to Neurodegeneration and AD While several biological, cognitive, and psychosocial mechanisms have been proposed to explain the association between hearing loss and cognitive decline, it remains challenging to determine the extent to which these pathways reflect causal effects, bidirectional interactions, or shared underlying age-related vulnerabilities. Although the association between hearing loss and increased dementia risk is well established, the mechanisms underlying this relationship remain the focus of ongoing debate and investigation. Recent literature suggests that there is no single causal pathway; rather, it comprises a constellation of convergent biological processes that couple auditory dysfunction with the neurodegenerative pathophysiology characteristics of AD. These pathways encompass cortical reorganization, compensatory cognitive load, psychosocial factors, and direct neurobiological mechanisms that collectively may diminish cognitive reserve and accelerate brain deterioration. The main proposed mechanisms linking hearing loss to cognitive decline and AD are summarized in Figure 2 and discussed below. Proposed mechanisms linking hearing loss to AD. Schematic representation of the main pathways linking hearing loss with cognitive decline and AD, including sensory deprivation, increased cognitive load, psychosocial factors, and shared neurobiological mechanisms. Bidirectional interactions are indicated to reflect the potential reciprocal relationship between auditory dysfunction and neurodegeneration. Sensory Deprivation and Cortical Reorganization The sensory deprivation hypothesis posits that chronic reductions in auditory stimulation led to structural and functional changes in cortical regions involved not only in auditory processing but also in higher-order cognition and memory [6, 8, 19, 21–24, 28]. Reduced sensory input may cause atrophy in temporal and parietal areas, thereby accelerating underlying neurodegenerative processes [6, 8, 19, 21–24, 28]. Evidence from human studies and animal models indicates that experimentally induced hearing loss can impair cognitive performance, suggesting a direct connection between diminished auditory input and neuronal vulnerability. Importantly, age-related declines in auditory processing and cognition often co-occur and interact, such that audiometric thresholds alone fail to capture the functional listening challenges experienced by older adults, reinforcing the need to consider central auditory and cognitive factors when interpreting hearing loss-cognition associations [29]. Recent reports further highlight that the relationship between hearing impairment and dementia may involve both causal effects and the amplification of ongoing neurodegenerative processes, reinforcing the bidirectional nature of the phenomenon [8]. Despite strong experimental and neuroimaging support, direct longitudinal human evidence linking sensory deprivation per se to dementia onset or progression remains limited, and its contribution likely varies across individuals and disease stages. Increased Cognitive Load When hearing loss occurs, particularly in degraded speech environments, the cognitive system is forced to allocate additional resources to decode acoustic information [6, 18, 19, 23, 24, 28]. This increased listening effort limits the resources available for functions such as working memory and reasoning. Although this mechanism is primarily functional, it may contribute to chronically reduced cognitive efficiency and, over time, greater susceptibility to decline [6, 18, 19, 23, 24, 28]. Observational studies consistently show a link between hearing impairment and poorer cognitive performance, supporting the notion that sustained cognitive load mediates the hearing loss-dementia pathway [6, 18, 19, 23, 24, 28]. In addition to effortful listening, sleep disturbances have recently been proposed as an important contributor to chronic cognitive load in individuals with hearing loss. Emerging evidence indicates that certain forms of auditory dysfunction, including hidden hearing loss, are associated with sleep fragmentation and altered sleep architecture. Since sleep plays a critical role in attention regulation, memory consolidation, and cognitive efficiency, chronic sleep disruption may magnify the cognitive load imposed by hearing impairment, leading to sustained reductions in cognitive performance and increased vulnerability to cognitive decline [30]. Nevertheless, capturing chronic cognitive load longitudinally remains challenging, and it is unclear whether sustained listening effort and sleep disruption operate as causal drivers of decline or as correlates of broader neurocognitive vulnerability. Social Isolation and Reduced Cognitive Stimulation Reduced social interaction represents another key pathway linking hearing loss to neurodegeneration [14, 19, 20, 25, 28, 31]. Communication difficulties diminish participation in social and cognitively stimulating activities, negatively affecting cognitive reserve [14, 19, 20, 25, 28, 31]. Epidemiological evidence identifies social isolation as a well-established risk factor for dementia, and since impaired hearing is a frequent trigger of social withdrawal, this pathway may represent one of the several interacting factors contributing to increased cognitive vulnerability observed in individuals with hearing impairment [19, 20, 25, 28, 31]. Recent systematic reviews corroborate that psychosocial consequences of hypoacusis play a significant role in progressive cognitive decline [14]. However, it is important to acknowledge that the mediating role of social isolation in the relationship between hearing loss and cognitive decline remains controversial. A recent systematic review and meta-analysis of longitudinal studies concluded that there is no consistent evidence supporting social isolation as a definitive mediator of this association, highlighting substantial heterogeneity in study design, duration of follow-up, and measurement of social engagement variables [32]. These findings suggest that social isolation may function as a contextual or amplifying factor rather than a universal mechanistic pathway, interacting with other cognitive and affective processes that contribute to neurodegenerative vulnerability [32]. In addition to social isolation, depression has emerged as a relevant psychosocial factor linking hearing impairment and cognitive deterioration. Individuals with hearing loss exhibit higher rates of depressive symptoms, which are independently associated with accelerated cognitive decline and dementia risk. Recent studies suggest that depression may act either as a parallel mediator or as an interacting factor with social isolation, further diminishing cognitive reserve and resilience in older adults with auditory dysfunction [33]. Shared Neuropathological Mechanisms An emerging line of research suggests that ARHL may share pathological mechanisms with Alzheimer’s pathology. Abnormal accumulation of Aβ and tau, the core pathogenic features of AD, may affect both the central nervous system and peripheral structures, including cochlear components [5, 6, 23, 34–36]. Elevated levels of phosphorylated tau have also been observed in the cerebrospinal fluid of individuals with ARHL, reinforcing the possibility of a direct biological connection between the two conditions [5, 6, 23, 34–36]. This overlap in molecular pathways suggests that hearing loss may signal a state of shared neurodegenerative vulnerability rather than solely functioning as an external risk factor. Nevertheless, recent longitudinal neuroimaging and biomarker studies have questioned the existence of a direct association between hearing loss and AD-specific pathology. In particular, recent evidence indicates no significant longitudinal relationship between hearing impairment and the accumulation of Aβ or tau pathology [37]. Similarly, studies assessing well-characterized population cohorts have reported no consistent association between peripheral hearing loss and AD-related biomarkers, further underscoring the complexity of linking auditory dysfunction with AD-specific pathology [38]. These findings suggest that the cognitive consequences associated with hearing loss may arise predominantly through functional, psychosocial, or non-Alzheimer-specific neurobiological mechanisms, underscoring the importance of distinguishing clinical cognitive decline from AD-related neuropathological processes [37]. Together, these findings argue against a unitary Alzheimer-specific neuropathological explanation for the hearing loss-cognition association and support a more heterogeneous, non-exclusive set of mechanisms. In addition, oxidative stress and oxidative damage have been proposed as potential shared mechanisms contributing to both auditory dysfunction and neurodegenerative processes, further supporting the concept of common age-related biological vulnerability [17]. Evidence of Bidirectionality: Implications for Neurodegeneration A critical question in current research is whether auditory deprivation precedes neurodegenerative processes within neural substrates associated with cognitive decline and dementia or, conversely, whether early cortical changes in AD contribute to central auditory processing deficits. Recent studies suggest that both directions are plausible and that hearing loss may act as a cause, catalyst, or consequence of neurodegenerative decline [5, 6, 8, 17, 22, 23, 35, 39]. Supporting this bidirectional framework, experimental studies in transgenic models of AD suggest that alterations in central auditory processing may emerge alongside early neurodegenerative changes, although the translational relevance of these findings to human aging remains uncertain [40]. This bidirectional framework has important implications for how the hearing loss-dementia association is interpreted and studied. If central auditory dysfunction reflects early cortical involvement rather than a downstream consequence of peripheral deprivation, then auditory deficits may act as prodromal markers of neurodegeneration rather than independent risk factors. This temporal ambiguity complicates causal inference in longitudinal studies and may partly explain inconsistent findings across cohorts. Importantly, it also suggests that the timing of auditory assessment and intervention may be more critical than the specific mechanism proposed, an aspect that remains insufficiently addressed in current research designs. This bidirectional complexity underscores the importance of distinguishing between peripheral and central hearing loss as central deficits may represent an early marker of AD-related cortical damage [5, 6, 8, 17, 22, 23, 35, 39]. Thus, bidirectionality should be viewed not as a limitation of current models but as a central feature of the complex relationship between auditory dysfunction and neurodegeneration. Evidence of Risk Modulation through Hearing Interventions Although definitive clinical trials are still lacking, robust observational data indicate that hearing interventions, particularly the use of hearing aids, may mitigate certain aspects of the cognitive risk associated with hypoacusis [5, 6, 24, 27, 39]. In fact, several studies indicate that individuals with hearing loss who use hearing aids have a lower risk of developing dementia compared with non-users, an association consistent with a potential benefit of preserved auditory and social stimulation, although evidence from randomized controlled trials is currently insufficient to establish a protective causal effect [5, 6, 24, 27, 39]. Supporting this view, a large systematic review and meta-analysis reported that the use of hearing aids or cochlear implants is associated with a reduced risk of long-term cognitive decline and incident dementia, although the authors emphasized the observational nature of the evidence and the likelihood of residual confounding [41]. More recently, randomized evidence from the ACHIEVE trial has shown that hearing intervention may slow cognitive decline in specific subgroups of older adults at increased risk of dementia, although no significant effect was observed in the overall study population, underscoring the heterogeneity of intervention effects [42]. In summary, these mechanisms illustrate how hearing loss can exert influence at multiple levels, from synaptic and molecular processes to social and cognitive dynamics, ultimately converging in an increased risk of neurodegeneration. The complexity of these pathways highlights the need for integrated approaches that simultaneously address the biological, functional, and psychosocial components of the relationship between hearing and AD. Nevertheless, to date, no high-quality interventional studies have conclusively demonstrated that hearing interventions prevent dementia, and existing findings should therefore be interpreted with appropriate caution. Together, these mechanistic and interventional findings reinforce the need to interpret the hearing loss-dementia association within a framework that acknowledges biological plausibility while recognizing persistent uncertainty. Overall, existing evidence supports cautious optimism regarding cognitive associations with hearing interventions, while underscoring the need for rigorous trials to clarify magnitude, timing, and durability of any potential effects. Central Hearing Loss: A Critical Nexus between Auditory Function and Neurodegeneration The distinction between peripheral and central hearing loss is essential for fully understanding the complex relationship between auditory decline and AD. In this context, systematic reviews and meta-analyses have demonstrated that central auditory processing deficits are consistently observed across preclinical and clinical stages of AD, often preceding overt cognitive symptoms, thereby supporting their potential role as early functional markers of cortical vulnerability [43, 44]. Whereas peripheral hearing loss involves damage to structures such as the cochlea or auditory nerve, central auditory processing disorder refers to impairments in the processing of auditory information within the central nervous system, particularly in cortical and subcortical regions responsible for interpreting and assigning meaning to sound [45–48]. Unlike peripheral loss, most often attributed to sensory aging, central hearing loss may directly reflect ongoing neurodegenerative alterations [45–48]. A growing body of evidence suggests that central auditory functions are particularly sensitive to early changes associated with AD [5, 8, 22, 24, 25, 28, 36, 48]. Recent studies indicate that the relationship between hearing impairment and dementia may involve not only causal effects but also the possibility that central auditory dysfunction represents an early symptom of neurodegeneration, reinforcing the bidirectional nature of this association [5, 8, 22, 24, 25, 28, 36, 48]. This perspective aligns with clinical observations showing that individuals with mild cognitive impairment or AD frequently present disproportionate difficulties in tasks requiring temporal discrimination, frequency resolution, or speech-in-noise recognition, even when peripheral hearing remains relatively preserved [8]. In addition, there is growing evidence that neuropathological mechanisms associated with AD may directly affect central auditory pathways. The accumulation of Aβ and phosphorylated tau, key markers of Alzheimer’s pathology, has been linked not only to cortical structures classically associated with memory but also to regions involved in auditory processing [5, 8, 22, 24, 25, 28, 36, 48]. Recent analyses highlight that Aβ and tau deposition, which begins long before the clinical onset of symptoms, may influence both the central nervous system and peripheral organs, providing a biological basis for understanding the convergence between hearing loss and AD [5, 6, 49]. Complementary human studies show elevated levels of phosphorylated tau in the cerebrospinal fluid of individuals with ARHL, suggesting a direct biological relationship between central auditory decline and the neurodegenerative processes characteristic of AD [6, 23]. Central auditory processing deficits may not only serve as an early manifestation of AD but could also contribute functionally to the progression of cognitive decline. Difficulties decoding speech, especially in complex acoustic environments, lead to a sustained increase in cognitive load devoted to auditory analysis, reducing resources available for processes such as working memory and attention [6, 18, 19, 23, 24, 28]. This phenomenon may interact with other mechanisms already described, such as sensory deprivation and social isolation, amplifying cognitive vulnerability. Taking together, current evidence highlights central hearing loss as a clinical and biological point of convergence between auditory dysfunction and neurodegeneration. Proper characterization of central auditory deficits not only deepens our understanding of the relationship between hearing loss and AD but also opens opportunities for identifying auditory biomarkers that could serve as early indicators of brain deterioration. In this context, several authors have proposed that central auditory tests may function as sensitive indicators of early cortical changes, with potential application in screening strategies and early diagnostic protocols [5, 28]. Early clinical studies already demonstrated that performance on central auditory tests deteriorates in individuals with mild cognitive impairment and AD, even after controlling for peripheral hearing sensitivity, suggesting that central auditory dysfunction reflects underlying cortical involvement rather than simple sensory deprivation [50, 51]. Nevertheless, whether central auditory dysfunction represents an early manifestation of neurodegeneration or a modifiable contributor to cognitive decline remains an open question. Why Does Uncertainty Persist? Methodological and Conceptual Challenges in Interpreting the Hearing Loss-Dementia Association Despite the growing body of epidemiological evidence demonstrating a robust association between hearing loss and cognitive decline, substantial uncertainty persists regarding the nature, directionality, and clinical significance of this relationship. The main sources of uncertainty shaping the interpretation of the hearing loss-dementia association, from epidemiological evidence to mechanistic models and clinical translation, are summarized in Figure 3. This uncertainty is not simply the result of insufficient data as the field is now supported by large population-based cohorts and multiple meta-analyses [9, 10, 13, 14]. Rather, it reflects a series of methodological, conceptual, and translational challenges that complicate causal inference and hinder definitive conclusions. Understanding these limitations is essential for interpreting existing findings appropriately and for guiding future research and clinical decision making [15, 21]. Sources of uncertainty and clinical interpretation of the hearing loss-dementia association. Conceptual overview summarizing the main sources of uncertainty in the relationship between hearing loss and dementia. The figure integrates epidemiological, mechanistic, and clinical perspectives, highlighting the role of residual confounding, reverse causation, heterogeneity in proposed pathways, and limitations in current interventional evidence. Together, these factors support a cautious interpretation of hearing loss as a potentially modifiable risk marker rather than a confirmed causal determinant. Population Level Risk versus Individual Vulnerability One of the principal sources of misinterpretation arises from the distinction between population attributable risk and individual level risk. Hearing loss consistently ranks highly among potentially modifiable risk factors for dementia in population-based models, such as those presented by the Lancet Commission [9, 10]. However, these rankings reflect the combined influence of prevalence and relative risk and do not necessarily indicate that hearing loss constitutes a dominant or primary driver of dementia risk in individual patients. Indeed, at the individual level, conditions such as depression, traumatic brain injury, diabetes, or low educational attainment may exert a greater influence on cognitive trajectories [9, 10]. Failure to distinguish between population level and individual level interpretations has contributed to overly simplified causal narratives regarding the role of hearing loss in dementia. Limitations of Observational Study Designs A second major challenge lies in the predominance of observational evidence. While longitudinal cohort studies provide important insights into temporal associations between hearing loss and cognitive decline [13, 14, 27], they remain inherently vulnerable to residual confounding. Hearing loss shares multiple risk factors with dementia, including vascular disease, frailty, inflammation, and social determinants of health, many of which are difficult to measure comprehensively or adjust for statistically [6, 21]. Reverse causation further complicates interpretation. Neurodegenerative changes affecting central auditory pathways may precede or coincide with measurable auditory dysfunction, giving rise to the appearance that hearing loss precedes cognitive decline when both may represent early manifestations of the same pathological process [8, 21]. This concern is particularly salient for central auditory processing deficits, which may act as functional markers of cortical vulnerability rather than independent risk factors [36, 48]. These limitations complicate causal interpretation of epidemiological associations and have important consequences for how evidence from hearing intervention studies should be interpreted. Heterogeneity in the Definition and Measurement of Hearing Loss Conceptual uncertainty is amplified by heterogeneity in how hearing loss is defined and measured. Most epidemiological studies rely primarily on pure tone audiometry, which captures peripheral auditory sensitivity but provides limited insight into everyday listening abilities, speech in noise perception, or central auditory processing [45, 46]. Consequently, individuals with similar audiometric thresholds may experience markedly different communicative demands and cognitive load, potentially contributing to inconsistent findings across studies. Moreover, hearing loss is often conceptualized as a static exposure, despite its progressive nature and the likelihood that duration, age of onset, and cumulative auditory deprivation influence long term cognitive outcomes [6, 52]. These factors remain insufficiently addressed in many longitudinal analyses. In addition, important conceptual distinctions are often blurred in the literature, including differences between subjectively reported hearing loss and audiometrically defined impairment, as well as between cognitive decline and clinically defined dementia, which may further contribute to heterogeneity in reported associations. Furthermore, in individuals with cognitive impairment or early dementia, elevated pure-tone thresholds may partly reflect attentional or cognitive limitations affecting test performance, which should be considered when interpreting audiometric data in these populations [29]. Moreover, most large-scale studies rely on all-cause dementia outcomes, despite the fact that dementia encompasses heterogeneous subtypes with distinct underlying pathophysiological mechanisms, which may partly explain variability in reported associations. Challenges in Interpreting Mechanistic Models Several mechanistic frameworks have been proposed to explain the association between hearing loss and dementia, including sensory deprivation, increased cognitive load, social isolation, sleep disturbances, and shared neurobiological processes [8, 19, 24, 31]. While these mechanisms are biologically plausible and supported by experimental and neuroimaging data, they should be regarded as conceptual models rather than definitive causal pathways [15, 21]. Importantly, mechanistic plausibility does not equate to causal proof. Increased cognitive load and reduced cognitive reserve, for instance, offer compelling explanatory frameworks but are difficult to quantify longitudinally and may themselves be influenced by broader factors such as depression or frailty [20, 25]. Similarly, recent longitudinal biomarker studies questioning a direct association between hearing loss and AD-specific pathology suggest that cognitive changes associated with hearing impairment may not be mediated through classic amyloid or tau driven pathways [36, 37]. Evidence Gaps in Hearing Intervention Studies Beyond questions of causal inference in observational studies, an additional layer of uncertainty concerns the translational interpretation of hearing intervention studies, particularly with regard to cognitive outcomes. Uncertainty is further reinforced by limitations in the interventional literature. Observational studies consistently report better cognitive outcomes among hearing aid users compared with non-users [24, 27, 31], findings often interpreted as supportive of a protective effect. However, such associations are particularly susceptible to selection bias related to health-seeking behavior, socioeconomic factors, and healthcare access [15, 21]. Recent target-trial emulation approaches using large population databases have further shown that associations between hearing aid use and reduced dementia risk are substantially attenuated after accounting for healthcare utilization patterns, underscoring the influence of selection bias and residual confounding in observational intervention studies [16]. Randomized controlled trials examining the cognitive effects of hearing interventions remain limited in number, duration, and methodological consistency. Given the long preclinical phase of dementia, the logistical and ethical challenges of conducting adequately powered trials with extended follow up are substantial. As emphasized in recent expert commentaries, the absence of conclusive interventional evidence should be interpreted cautiously and not conflated with proof of inefficacy [15]. Clinical Interpretation under Conditions of Uncertainty The persistence of uncertainty does not negate the clinical relevance of hearing loss; rather, it necessitates a balanced and transparent interpretation. Recent professional guidance emphasizes that hearing loss should be discussed with patients as a potentially modifiable marker of dementia risk rather than a confirmed causal determinant [8, 15]. Hearing interventions should therefore be recommended primarily for their established benefits on communication, social participation, and quality of life, while any potential cognitive effects should be communicated cautiously and without overstatement [8, 9, 15]. This approach aligns with expert viewpoints advocating for responsible clinical messaging that avoids deterministic claims while still recognizing the importance of auditory health within multidomain strategies for healthy aging [15]. Toward a Refined Research Agenda Collectively, these challenges underscore the need for more refined research approaches. Future efforts should prioritize improved phenotyping of auditory function, clearer differentiation between peripheral and central hearing loss, longer follow up periods, and greater integration of neuroimaging and biomarker data [8, 48]. In this context, the development and validation of clinically applicable central auditory tests will be essential to better address reverse causation and to distinguish between peripheral sensory decline and early manifestations of neurodegeneration. Equally important is the development of pragmatic trial designs capable of capturing meaningful cognitive and functional outcomes over extended timeframes. In this context, the central question may no longer be whether hearing loss is associated with dementia, a relationship now well established, but under what conditions, through which mechanisms, and for whom auditory interventions may meaningfully influence cognitive trajectories. Addressing these questions is essential for translating epidemiological associations into clinically actionable knowledge. Clinical Implications Clinical implications should be interpreted in the context of current uncertainty regarding causality and intervention effects. Recognizing hearing loss as a potentially modifiable risk factor for cognitive decline and AD has profound implications for clinical practice, public health, and preventive strategies [9, 10, 52]. The strength of the epidemiological evidence, combined with the growing understanding of the biological and functional mechanisms linking auditory dysfunction to neurodegeneration, places hearing assessment at the forefront of comprehensive approaches to cognitive aging. First, the magnitude of the associated risk, with a 35% increase in the likelihood of developing dementia and more than a 50% increase in AD risk among individuals with hearing loss, underscores the need to integrate systematic hearing screening into primary care and geriatric assessment programs [13]. Given the high prevalence and frequent underdiagnosis of hypoacusis, early identification provides a valuable window of opportunity for preventive interventions before irreversible neurodegenerative changes occur. In this context, the use of hearing aids emerges as a clinically significant intervention. In this regard, as outlined earlier, results from numerous studies reveal that hearing-impaired individuals who utilize hearing aids have a significantly lower incidence of dementia relative to non-users, supporting the hypothesis that sustained auditory enrichment and the preservation of communicative engagement may exert neuroprotection [5, 6, 8, 13, 18, 19, 24, 27]. The previously mentioned population-based study in Denmark found that participants with hearing loss who did not use hearing aids had a higher risk of developing dementia compared with those who did, reinforcing the importance of promoting accessible auditory interventions [27]. Similarly, recent meta-analyses support the idea that hearing interventions may delay, or even prevent, cognitive decline, although randomized controlled trials are still required to draw definitive conclusions [13]. Another key implication is the need to adequately differentiate peripheral from central hearing loss in clinical practice. Since central auditory dysfunction may reflect early cortical changes characteristic of AD, central auditory processing tests may become useful diagnostic tools, potentially serving as early indicators of cognitive vulnerability [5, 8, 22, 24, 25, 28, 36, 48]. Several studies have highlighted the value of central auditory tests as potential auditory biomarkers of neurodegeneration, opening a promising approach for early detection of AD [5, 8, 22, 24, 25, 28, 36, 48]. Finally, the strong interaction between hearing loss, increased cognitive load, and social isolation implies that hearing rehabilitation must be a core component of strategies designed to promote healthy aging. Interventions that facilitate communication, such as access to hearing aids, assistive technologies, or auditory training, have the potential not only to improve quality of life but also to preserve cognitive networks through the maintenance of sensory and social stimulation. Overall, these clinical implications reinforce the central message that “hearing loss should not be viewed as a benign aspect of aging, but rather as a critical signal requiring proactive evaluation and management”. Integrating auditory health into geriatric care protocols, expanding access to hearing interventions, and exploring their utility as early detection tools are essential steps toward reducing the burden of neurodegeneration in the coming decades. Conclusion The accumulated evidence of recent years supports the view that hearing loss is robustly associated with cognitive decline and dementia, including AD, rather than establishing a definitive causal relationship. As previously stated, epidemiological studies robustly show that hearing loss is associated with increases in the risk of dementia, including AD, with estimates placing this increase between 30% and 50%, depending on the type and severity of the auditory deficit [13]. This elevated risk, together with evidence supporting a potential dose-response relationship, underscores the importance of considering hearing as a priority target in public health policies aimed at preventing cognitive decline. The mechanisms linking hearing loss to neurodegeneration are multiple and convergent. From sensory deprivation and cortical reorganization to increased cognitive load, social isolation, and possible shared neuropathological pathways, including the accumulation of Aβ and tau, the routes connecting hearing to AD reflect a complex interplay of biological, cognitive, and psychosocial factors [6, 19, 25, 28, 31]. Growing evidence identifying central auditory dysfunction as a potential early marker of AD adds an additional layer of clinical relevance, suggesting that certain auditory deficits may precede cortical changes long before the clinical manifestation of symptoms. From a clinical perspective, recognizing hearing loss once and for all as a modifiable risk factor opens meaningful opportunities [9, 10]. Integrating systematic hearing assessments, distinguishing between peripheral and central loss, and promoting hearing aid use and other auditory interventions emerge as promising strategies to reduce risk or slow the progression of cognitive decline. Current findings suggest that individuals with hypoacusis who use hearing aids may experience a lower risk of developing dementia in observational studies; however, this association should be interpreted with caution given the potential influence of selection bias, adherence-related factors, and residual confounding. In summary, the accumulated evidence supports a robust and reproducible association between hearing loss and cognitive decline, including dementia, while falling short of establishing a definitive causal pathway or quantifying the preventive impact of hearing interventions. The persistence of uncertainty reflects not a lack of evidence, but fundamental methodological and conceptual challenges, including residual confounding, reverse causation, heterogeneity in auditory phenotyping, and limitations inherent to observational and interventional study designs. Within this context, hearing loss is best regarded at present as a potentially modifiable marker of dementia risk rather than a confirmed causal determinant. This distinction has important implications for both research and clinical practice, underscoring the need for cautious interpretation, transparent patient communication, and integration of auditory care within broader, multidomain strategies for healthy cognitive aging. Further progress will depend on refined phenotyping, long-term longitudinal studies, and pragmatic trials capable of clarifying when, how, and for whom addressing hearing loss may meaningfully influence cognitive trajectories. Conflict of Interest Statement The authors have no conflicts of interest to declare. Funding Sources This study was not supported by any sponsor or funder. Author Contributions Conceptualization and resources: Juan Carlos Alvarado and Verónica Fuentes-Santamaría. Writing – original draft, writing – review and editing, and visualization: Juan Carlos Alvarado, Verónica Fuentes-Santamaría, and Carmen María Díaz García. Supervision: Juan Carlos Alvarado. Verónica Fuentes-Santamaría and Juan Carlos Alvarado have contributed equally to this work and share senior authorship.